[go: up one dir, main page]

NO20065030L - Aerosolformulering for inhalering av beta agonister. - Google Patents

Aerosolformulering for inhalering av beta agonister.

Info

Publication number
NO20065030L
NO20065030L NO20065030A NO20065030A NO20065030L NO 20065030 L NO20065030 L NO 20065030L NO 20065030 A NO20065030 A NO 20065030A NO 20065030 A NO20065030 A NO 20065030A NO 20065030 L NO20065030 L NO 20065030L
Authority
NO
Norway
Prior art keywords
inhalation
aerosol formulation
beta agonists
agonists
beta
Prior art date
Application number
NO20065030A
Other languages
English (en)
Inventor
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065030(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065030L publication Critical patent/NO20065030L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Det beskrives en drivgassfri aerosolformulering som inneholder én eller flere forbindelser med den generelle formel (1), hvor restene R', R2 , R3 og X- kan ha de betydninger som er angitt i kravene og i beskrivelsen, for inhalasjon.
NO20065030A 2004-05-14 2006-11-02 Aerosolformulering for inhalering av beta agonister. NO20065030L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (de) 2004-05-14 2004-05-14 Aerosolformulierung für die Inhalation von Betaagonisten
PCT/EP2005/005028 WO2005110421A2 (de) 2004-05-14 2005-05-10 Aerosolformulierung für die inhalation von betaagonisten

Publications (1)

Publication Number Publication Date
NO20065030L true NO20065030L (no) 2006-11-30

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065030A NO20065030L (no) 2004-05-14 2006-11-02 Aerosolformulering for inhalering av beta agonister.

Country Status (26)

Country Link
EP (1) EP1809293B1 (no)
JP (1) JP4620730B2 (no)
KR (1) KR101288791B1 (no)
CN (1) CN101056640A (no)
AR (1) AR049096A1 (no)
AU (1) AU2005244414B2 (no)
BR (1) BRPI0511135B8 (no)
CA (1) CA2564379C (no)
DE (1) DE102004024452A1 (no)
DK (1) DK1809293T3 (no)
EA (1) EA012583B1 (no)
EC (1) ECSP067004A (no)
ES (1) ES2575925T3 (no)
HU (1) HUE027780T2 (no)
IL (1) IL179218A (no)
MX (1) MXPA06013216A (no)
MY (1) MY148403A (no)
NO (1) NO20065030L (no)
PE (1) PE20060311A1 (no)
PL (1) PL1809293T3 (no)
SG (1) SG152265A1 (no)
TW (1) TWI356703B (no)
UA (1) UA87312C2 (no)
UY (1) UY28891A1 (no)
WO (1) WO2005110421A2 (no)
ZA (1) ZA200607462B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
PL1917253T3 (pl) 2005-08-15 2015-06-30 Boehringer Ingelheim Int Sposób wytwarzania betamimetyków
JP2009514933A (ja) * 2005-11-09 2009-04-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入用エアロゾル製剤
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
JP2012509299A (ja) * 2008-11-21 2012-04-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング β作用薬吸入用のエアロゾル製剤
EP2358353A1 (en) * 2008-11-21 2011-08-24 Boehringer Ingelheim International GmbH Aerosol formulation for the inhalation of beta agonists
WO2014056840A1 (en) 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (de) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim Neue benzo-heterocyclen
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004019539A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
DK2422786T3 (da) * 2004-04-22 2014-11-17 Boehringer Ingelheim Int Nye lægemiddelkombinationer til behandling af luftvejssygdomme
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004024451A1 (de) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten

Also Published As

Publication number Publication date
WO2005110421A3 (de) 2006-03-16
TWI356703B (en) 2012-01-21
KR20070022084A (ko) 2007-02-23
ES2575925T3 (es) 2016-07-04
DE102004024452A1 (de) 2005-12-08
TW200608981A (en) 2006-03-16
EP1809293A2 (de) 2007-07-25
MY148403A (en) 2013-04-30
AR049096A1 (es) 2006-06-28
ECSP067004A (es) 2007-02-28
UY28891A1 (es) 2005-12-30
PL1809293T3 (pl) 2016-09-30
SG152265A1 (en) 2009-05-29
JP4620730B2 (ja) 2011-01-26
HUE027780T2 (en) 2016-11-28
IL179218A0 (en) 2007-03-08
AU2005244414A1 (en) 2005-11-24
CA2564379A1 (en) 2005-11-24
BRPI0511135B8 (pt) 2021-05-25
EP1809293B1 (de) 2016-03-16
MXPA06013216A (es) 2007-02-08
KR101288791B1 (ko) 2013-07-29
EA012583B1 (ru) 2009-10-30
DK1809293T3 (en) 2016-06-20
CA2564379C (en) 2013-07-30
EA200602017A1 (ru) 2007-06-29
UA87312C2 (ru) 2009-07-10
AU2005244414B2 (en) 2010-12-09
JP2007537188A (ja) 2007-12-20
IL179218A (en) 2012-10-31
CN101056640A (zh) 2007-10-17
PE20060311A1 (es) 2006-05-08
BRPI0511135A (pt) 2007-11-27
ZA200607462B (en) 2008-06-25
BRPI0511135B1 (pt) 2019-11-12
WO2005110421A2 (de) 2005-11-24

Similar Documents

Publication Publication Date Title
NO20065030L (no) Aerosolformulering for inhalering av beta agonister.
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20090410L (no) Aerosolformuleringer for inhalaering av beta-agonister
NO20050828L (no) lndol-3-svovelderivater
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
AU2003228770A8 (en) Substituted pyrazolopyrimidines
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
ATE433447T1 (de) Pyrimiidinverbindungen
NO20034011L (no) Steroider som agonister for FXR
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20065060L (no) Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
WO2004100865A3 (en) New benzimidazole derivatives
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
ATE300541T1 (de) Pyrazolopyridinderivate
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
NO20040881L (no) Orale antidiabetes midler.
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
NO20081587L (no) Aerosolformulering for inhalering
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
ATE274515T1 (de) Pyrazolopyridinderivate
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application